Altaviva™ implant for bladder control for urge urinary incontinence

Take the next step with Altaviva™ therapy

Discover the Altaviva™ therapy advantage and get access to helpful resources and support.

Indications, Safety, and WarningsIndications for useTibial Neuromodulation delivered by the Altaviva™ system is indicated for treatment of urge urinary incontinence (UUI) in patients who failed or could not tolerate more conservative treatments.ContraindicationsPoor surgical candidates including patients with skin lesions or compromised skin integrity; current or recent history of venous insufficiency and/or venous stasis ulcers in the lower leg; anatomical defects or previous surgeries at the implant site which preclude use of the device. Patients who are not able to operate or receive assistance in operating the system. WarningsThis therapy is not intended for patients who are considered poor candidates for surgery or are at risk for poor wound healing including, but not limited to, severe uncontrolled diabetes, clinically significant edema in the lower leg, clinically significant peripheral neuropathy, nerve damage, or a neurological condition affecting the lower leg. Do not implant the neurostimulator within 5 cm of another metal implant. This therapy is also not intended for patients with current or unresolved mechanical obstruction such as caused by benign prostatic hypertrophy, cancer, or urethral strictures, or patients with known allergies to any of the materials in the Altaviva™ neurostimulator. Continuous stimulation should not be used as safety and effectiveness have not been established. Safety and effectiveness have also not been established for pregnant women; patients under the age of 18; patients with progressive, systemic neurologic disease; patients with history of urinary retention; bilateral leg stimulation. Diathermy (shortwave and microwave) should not be used on patients with a neurostimulator, as it can cause tissue damage or device damage. The Altaviva™ system may affect the operation of other implanted or external systems. The Altaviva™ system may interfere with the operation of other implanted cardiac devices such as pacemakers and defibrillators. Recharging the neurostimulator within 5 cm of a metal implant may cause recharge heating leading to tissue damage. Do not use the recharger or ankle band in direct contact with an unhealed wound. MRI WarningsPrior to an MRI scan, determine if the patient has multiple active or abandoned medical device implants. The most restrictive MRI exposure requirement must be used. MRI scans with another metal implant less than 3 cm away from the Altaviva™ neurostimulator have not been tested, and scanning may cause excessive tissue heating surrounding the device resulting in tissue damage and possible need for surgical intervention.Adverse EventsIn addition to the risks normally associated with surgery, adverse events may include pain at the implant site, infection, reaction to local anesthesia, wound complications, lower leg pain, nerve injury, movement of the implant, adverse change in bowel or urinary function, uncomfortable or unintended stimulation sensations or an inappropriate shock sensation, loss of therapeutic effect, discomfort during recharge, or technical or device problems. For full prescribing information, refer to the product manuals at www.medtronic.com. Product manuals must be reviewed prior to use for detailed disclosure. USA Rx Only. Rev 0925

M028949C001 RevC - MRI Guidelines for Altaviva™ Neurostimulator.
eCoin® Peripheral Neurostimulator System Patient Manual_903-1236 revPB.
Magnetic Resonance Imaging (MRI) for the Revi™ System G02- CLU-0139 Rev.02 May 2024.
M028929C001 RevC - Clinician Therapy and Programming Guide Altaviva™ Model P7850N.
Revi™ - Surgical Technique Guide US Catalog No: G02-CLU-0131 Rev 03 December, 2023.
Shah A, Aran S. A Review of Magnetic Resonance (MR) Safety: The Essentials to Patient Safety. Cureus. 2023;15(10):e47345. Published 2023 Oct 19. doi:10.7759/cureus.47345.
World Metrics. MRI statistics: report 2026.https://worldmetrics.org/ mri-statistics. Accessed April 29, 2026.
Medtronic data on file: Quantitative EnRhythm SureScan MRI Needs Assessment Research Presentation 2009.
D01314170 Rev A - Overdrive Chemistry Battery Accelerated Cycling Performance.

Take the next step with Altaviva™ therapy

The only tibial neuromodulation device...

Full-body† MRI ready from the start with therapy on1-3

15-year Overdrive™ battery technology‡,2,4,5

Same-day therapy activation2,4,5

Discover the Altaviva™ therapy advantage

Broad MRI compatibility

1.5 and 3T full-body† MRI conditional1

Broad access. Unparalleled expertise.

Backed by 20+ years of Medtronic MRI research.

See the difference.

With Altaviva™ therapy, today’s implant decision considers tomorrow’s care for your patients with urge urinary incontinence.

MRI needs can present at any point in a patient’s care journey.

MRI scans are performed in the U.S. annually6

Americans will receive an MRI this year.7

MRIs by speciality8

15-year Overdrive™ battery technology‡,4

The most powerful§ ITNM battery on the market.

Engineered not outsourced.

Our proprietary Overdrive™ technology prevents battery degradation over time.

This means your Altaviva™ therapy patients can expect the same recharge performance in year 15 as in year one.9

Powered by ~70 years◊ of Medtronic expertise

From pacemakers to neurostimulators — the Altaviva™ device battery offers the same reliability as our life-changing pacemakers.

Offer your patients the longest-lasting implantable tibial neuromodulation device on the market.4

Same-day therapy activation4

With Altaviva™ therapy, you don’t have to wait to activate.

Why wait? Implant and activate. Today.

Altaviva™ therapy is the only implantable tibial neuromodulation system that enables same-day therapy activation. 4

This means one less office visit and therapy delivery starts on day 1.

The Altaviva™ therapy system can begin delivering therapy the day of the implant procedure, streamlining the patient experience and clinic workflow.

Help your UUI patients today.

Support that never stops

Find resources, tools and support to help you get started.

Ready to take the next step with Altaviva™ therapy?

We have resources, tools and support to help you get started

Contracting

VAC approval assistance

Value Analysis Committee (VAC) packet

Healthcare economics manager (HEM) support

Reimbursement

Prior-auth, coding and coverage guidance

Reimbursement guide

Prior authorization support

Patient education

Tools and resources to build understanding

Altaviva™ therapy patient materials

MyFuture™ app and insights dashboard

Therapy awareness

Spread the word to expand patient access

Co-marketing program

Therapy awareness programs/events

Connect with your Medtronic Altaviva™ therapy representative

What are you interested in speaking with the Altaviva™ therapy rep about?

Contracting

Reimbursement

Patient education

Therapy awareness

Please complete the fields below and your Altaviva™ therapy rep will contact you shortly.

Sign up for updates

United States

Customer Care Team

Full-body^† MRI ready
from the start with therapy on^1-3

15-year
Overdrive™ battery
technology^‡,2,4,5

Same-day
therapy
activation^2,4,5

1.5 and 3T full-body^† MRI conditional¹

MRI scans are performed in the U.S. annually⁶

Americans will receive an MRI this year.⁷

MRIs by speciality⁸

15-year Overdrive™ battery technology^‡,4

The most powerful^§ ITNM battery on the market.

This means your Altaviva™ therapy patients can expect the same recharge performance in year 15 as in year one.⁹

Powered by ~70 years^◊ of Medtronic expertise

Offer your patients the longest-lasting implantable tibial neuromodulation device on the market.⁴

Same-day therapy activation⁴

Altaviva™ therapy is the only implantable tibial neuromodulation system that enables same-day therapy activation. ⁴